How to Identify Malabsorption Issues
The most effective way to identify malabsorption is through a systematic diagnostic approach that includes screening blood tests, specific antibody testing, and targeted endoscopic evaluation with biopsies when indicated. 1, 2
Initial Screening Tests
- Full blood count, erythrocyte sedimentation rate, C-reactive protein, electrolytes, liver function tests, calcium, vitamin B12, folate, iron studies, and thyroid function tests should be performed as first-line screening - these have high specificity but low sensitivity for organic disease 1, 2
- Stool cultures and microscopy should be performed to rule out infectious causes, even though these are uncommon in immunocompetent patients with chronic symptoms 1
- Confirmation of true diarrhea through stool inspection and measurement is recommended before pursuing extensive malabsorption workup 2
Specific Testing for Common Causes
Celiac Disease
- Antiendomysium antibody testing is the preferred first-line test for celiac disease, which is the most common small bowel enteropathy in Western populations 1, 3, 2
- If serological tests are negative but small bowel malabsorption is still suspected, upper gastrointestinal endoscopy with distal duodenal biopsies should be performed 1, 3
Pancreatic Insufficiency
- Newer specific tests such as stool elastase are preferred over older methods like quantification of three-day fecal fat 1, 2
- Pancreatic enzyme treatment should not be used as a diagnostic trial due to expense and variable efficacy without proper dose adjustment 1
Fat Malabsorption
- Traditional three-day fecal fat quantification is poorly reproducible, unpleasant, and non-diagnostic - its use is discouraged 1, 2
- Breath tests for fat malabsorption (using 14C-triolein or 13C-labeled mixed triglyceride) may serve as alternatives to fecal fat collection but have low sensitivity for mild/moderate fat malabsorption 1
Carbohydrate Malabsorption
- Carbohydrate malabsorption is predominantly associated with mucosal disease or dysfunction 1
- Hydrogen breath tests offer better diagnostic value for specific carbohydrate intolerances than stool pH or reducing substances 2
Specialized Testing Based on Clinical Suspicion
Bile Acid Malabsorption
- Consider bile acid malabsorption in patients with IBS-D who have atypical features such as nocturnal diarrhea or prior cholecystectomy 1, 4
- SeHCAT nuclear medicine test is the de facto gold standard for diagnosing bile acid malabsorption but is not available in all countries 1
- Blood tests measuring C4 and FGF19 can be used where available 1
Small Bowel Imaging
- Small bowel imaging (barium follow-through or enteroclysis) should be reserved for cases where small bowel malabsorption is suspected and distal duodenal histology is normal 1
- Technetium HMPAO-labeled white cell scanning can be used to examine for intestinal inflammation 1
Important Clinical Pitfalls
- Factitious diarrhea becomes increasingly common in specialist referral practice - screening for laxative abuse should be performed early in the investigation 1
- Patients should not restrict their diets before testing for malabsorption syndromes as this may affect diagnostic accuracy 5
- Malabsorption may present with subtle extraintestinal manifestations (anemia, osteoporosis, neurological symptoms) without obvious gastrointestinal symptoms 6, 7
- In patients under 45 years with typical symptoms of functional bowel disorder and negative initial investigations, a diagnosis of IBS may be made without further investigations 1
When to Refer to Gastroenterology
- Referral is warranted when there is diagnostic doubt, symptoms are severe or refractory to first-line treatments, or the patient requests specialist opinion 4
- Patients with documented diarrhea who are under 45 years with atypical and/or severe symptoms should have further evaluation beyond initial screening 1
Remember that malabsorption can be caused by numerous disorders affecting the small intestine, pancreas, liver, biliary tract, and stomach, requiring a targeted diagnostic approach based on clinical presentation and initial test results 6.